When it comes to inhalation APIs, precision, consistency, and regulatory confidence are not optional—they are essential. Pharmaceutical companies developing inhaled therapies face the constant challenge of ensuring that every particle, every formulation, and every process step meets the highest standards of performance and safety. The complexity of delivering active ingredients directly to the lungs requires deep scientific understanding and specialized manufacturing expertise. At Inke, we empower our partners to overcome these challenges through a fully integrated approach to the development and production of inhalation-grade active pharmaceutical ingredients (APIs). Our focus lies in supporting innovators and generic manufacturers who need reliable, high-quality APIs specifically optimized for respiratory drug delivery.
Our unwavering commitment ensures that they receive the highest quality assistance to achieve their goals. With a strategic vision deeply rooted in respiratory care, we specialize in the development and manufacturing of high-added-value active ingredients tailored specifically for inhalation therapies. For over two decades, Inke has led the charge in technology, driving the evolution of respiratory active pharmaceutical ingredients to meet the ever-evolving needs of patients and healthcare providers worldwide.